4D Biomaterials partners with BMF to enable medical applications in 3D micro-printing with 4Degra bioabsorbable materials



Boston micro-manufacturing (BMF) and 4D biomaterials have announced a partnership that aims to enable medical micro 3D printing applications.

The collaboration combines BMF’s micro-scale 3D printing systems with 4Degra bioabsorbable materials from 4D Biomaterials and will facilitate the printing of micro-scale geometries.

BMF and 4D Biomaterials suggest their partnership could “revolutionize the way implantable medical devices are manufactured” as they open up opportunities for the additive manufacturing of micro-scale rigid orthopedic devices and soft tissue applications. By combining 4Degra’s bioresorbable materials with BMF’s micro-stereolithography (PµSL), the companies believe they solve many of the design and biocompatibility challenges posed by medical device manufacturers.

PµSL is the 3D printing process that underpins BMF’s product portfolio – which includes the microArch S240 and microArch S230 systems – and is capable of delivering high-resolution micro-scale components through high-precision optics, advanced digital micro-display and top-down printing. 4Degra, on the other hand, is a class of bioabsorbable photopolymer resin-based inks that can be 3D printed in flexible or rigid devices that promote tissue repair, before degrading in a controlled manner into benign byproducts and absorbable.

“Our customers continue to seek solutions to miniaturize and now, with bioabsorbable material options, a whole new range of devices is possible,” commented John Kawola, CEO of BMF. “Miniaturization in the development of medical devices has been hampered by the limitations of traditional manufacturing methods and the materials available. The BMF and 4D Biomaterials partnership strives to remove these barriers.

“This partnership with BMF represents a huge opportunity for printing micro-structures. We are enabling medical device companies to think for the first time about 3D printing micro-absorbable implants, ”added Philip Smith, CEO of 4D Biomaterials. “The bioresorbable polymers market is estimated at USD 1.0 billion in 2021 and is expected to reach USD 1.6 billion by 2026. We are already seeing demand from this market growth as the range of applications continues to expand. expand with advancements in hardware, software. and materials technology.

Want to discuss ? Join the conversation on the Global Additive Manufacturing Community Discord.

Get your FREE print subscription to TCT Magazine.



Comments are closed.